B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target?
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
- Status
- RECRUITING
- Phase
- N/A
BLood Groups as Biomarker to Optimize Odds of Response to Anti-PD-1 Drugs
- Status
- TERMINATED
- Phase
- N/A
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
PD-L1 Expression in Cancer (PECan Study).
- Status
- UNKNOWN
- Phase
- NA
Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment
- Status
- COMPLETED
- Phase
- N/A
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant T-VEC in High Risk Early Melanoma
- Status
- SUSPENDED
- Phase
- PHASE2
Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access
- Status
- COMPLETED
- Phase
- NA
Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence
- Status
- TERMINATED
- Phase
- PHASE3
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab
- Status
- COMPLETED
- Phase
- PHASE2
Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
OH2 Injection in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2